GFAPα IgG-associated encephalitis upon daclizumab treatment of MS
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received April 16, 2018
- Accepted in final form May 31, 2018
- First Published July 13, 2018.
Author Disclosures
- Felix Luessi, MD*,
advisory board member for Roche Pharma
travel grants from Teva Pharma and Merck Serono
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Sinah Engel*,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Annette Spreer, MD,
NONE
NONE
(1) Deutsche Gesellschaft f?r Liquoranalytik und Neurochemie, funding for travel to speak at conferences and Workshops (2) Institut Virion/Serion GmbH, W?rzburg, funding for travel to speak at educational workshop
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
BMG /RKI, #1369-487, Lead investigator,2015-2017
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Stefan Bittner, MD and
NONE
NONE
S.B. has received honoraria for travel or speaker honoria from Biogen Idec, Merck Serono, Novartis, Roche and Sanofi- Genzyme.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Frauke Zipp, MD
NONE
NONE
(1) Teva, research grant and travel compensation (2) Novartis, research grant, consultation funds and travel compensation (3) Merck Serono, research grant and travel compensation (4) Bayer, research grant and travel compensation (5) Biogen Idec Germany, consultation funds and travel funds (6) Ono, consultation funds and travel funds (7) Genzyme, consultation funds and travel funds (8) Sanofi-Aventis, consultation funds and travel funds (9) Octapharma, consultation funds and travel funds
NONE
NONE
NONE
NONE
(1) Teva (2) Merck Serono (3) Novartis (4) Bayer Healthcare (5) Biogen Idec Germany (6) Ono (7) Genzyme (8) Sanofi-Aventis (9) Octapharma
NONE
NONE
NONE
NONE
(1) DFG CRC128, Spokesperson/PI, 2012-2020 (2) DFG CRC1080, PI, 2013-2020 (3) BMBF KKNMS, Executive Board/PI, 2013-2019 (4) PCORI PRAG-MS, Director Subcontracted Organization, 2017-2021
NONE
Progressive MS Alliance - BRAVEinMS
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology and Focus Program Translational Neuroscience (FTN), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Germany.
- Correspondence
Dr. Luessi luessi{at}uni-mainz.de
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
CD56bright natural killer cells and response to daclizumab HYP in relapsing-remitting MSJ. Elkins, J. Sheridan, L. Amaravadi et al.Neurology - Neuroimmunology Neuroinflammation, January 28, 2015 -
What's Happening
What's happening in Neurology® Neuroimmunology & Neuroinflammationet al.Neurology, February 25, 2019 -
Article
Patients with MS under daclizumab therapy mount normal immune responses to influenza vaccinationYen Chih Lin, Paige Winokur, Andrew Blake et al.Neurology - Neuroimmunology Neuroinflammation, January 27, 2016 -
Article
Effect of dimethyl fumarate on lymphocytes in RRMSImplications for clinical practiceDevangi Mehta, Catherine Miller, Douglas L. Arnold et al.Neurology, March 27, 2019